Skip to content
2000
Volume 9, Issue 12
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Bisphosphonates (BP) are pyrophosphate analogs having a P-C-P backbone. The oral bioavailability of BPs is ca. 1%, due to high ionisation at physiological pH. Using the prodrug approach, oral absorption can be increased by masking one or more ionizable groups (clodronate, etidronate), or using a targeting carrier system (alendronate, pamitronate).

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867023369998
2002-06-01
2025-04-06
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867023369998
Loading

  • Article Type:
    Review Article
Keyword(s): bisphosphonate; clodronate; etidronate; pyrohosphate analogs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test